Anakinra and Intravenous IgG versus Tocilizumab in the Treatment of COVID-19 Pneumonia

Massa Zantah, Eduardo Dominguez Castillo, Andrew J. Gangemi, Maulin Patel, Junad Chowdhury, Steven Verga, Osheen Abramian, Matthew Zheng, Kevin Lu, Arthur Lau, Justin Levinson, Hauquing Zhao, Gerard J. Criner, Roberto Caricchio, for the Temple University COVID-19 Research Group
doi: https://doi.org/10.1101/2020.09.11.20192401

Article usage

Article usage: September 2020 to June 2025

AbstractFullPdf
Sep 20206160138
Oct 2020288065
Nov 2020244063
Dec 2020200047
Jan 2021275046
Feb 2021153128
Mar 2021153424
Apr 2021191633
May 2021147036
Jun 2021116218
Jul 2021102424
Aug 202190730
Sep 2021101421
Oct 202173029
Nov 202185124
Dec 20214234
Jan 202253513
Feb 202232212
Mar 202243218
Apr 202235115
May 202234219
Jun 20223007
Jul 20221916
Aug 20221716
Sep 202232511
Oct 202231111
Nov 20222827
Dec 20222119
Jan 20232413
Feb 20231638
Mar 20231007
Apr 202322115
May 202312316
Jun 20231347
Jul 20231405
Aug 2023191311
Sep 20231275
Oct 202320210
Nov 202322147
Dec 20231216
Jan 20241928
Feb 20241004
Mar 20241828
Apr 20241548
May 20242116
Jun 202424613
Jul 20241609
Aug 20241828
Sep 202427415
Oct 202411720
Nov 202420610
Dec 2024719
Jan 2025939
Feb 2025221623
Mar 2025732852
Apr 202519018
May 202517510
Jun 202538814
Back to top
Posted September 13, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Anakinra and Intravenous IgG versus Tocilizumab in the Treatment of COVID-19 Pneumonia
Massa Zantah, Eduardo Dominguez Castillo, Andrew J. Gangemi, Maulin Patel, Junad Chowdhury, Steven Verga, Osheen Abramian, Matthew Zheng, Kevin Lu, Arthur Lau, Justin Levinson, Hauquing Zhao, Gerard J. Criner, Roberto Caricchio, for the Temple University COVID-19 Research Group
medRxiv 2020.09.11.20192401; doi: https://doi.org/10.1101/2020.09.11.20192401
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area